Sanofi Genzyme and Regeneron have emerged as leaders in dermatology with DUPIXENT®, the only biologic approved for atopic dermatitis and the only treatment that specifically targets the type 2 inflammation that plays a major role in certain dermatological and respiratory diseases. Our research of the science behind type 2 inflammation is a key area of focus for us and one in which we’ve already made an impact, with expanded indications for Dupixent in asthma and CRSwNP, and a robust pipeline including chronic spontaneous urticaria, prurigo nodularis and bullous pemphigoid, as well as paediatric asthma, eosinophilic esophagitis and COPD.

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eycare, virology, women’s health and gastroenterology. For more information about AbbVie, please visit us at Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

The owner of this channel is LEO Pharma A/S LEO Pharma is an independent, research-based pharmaceutical company dedicated to helping people achieve healthy skin. LEO Pharma develops, manufactures and markets pharmaceutical products and services to dermatologic and thrombotic patients in more than 100 countries globally.

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.”

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.